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Abstract
Background: Low back pain is a substantial health problem and has subsequently attracted a
considerable amount of research. Clinical trials evaluating the efficacy of a variety of interventions
for chronic non-specific low back pain indicate limited effectiveness for most commonly applied
interventions and approaches.
Discussion: Many clinicians challenge the results of clinical trials as they feel that this lack of
effectiveness is at odds with their clinical experience of managing patients with back pain. A
common explanation for this discrepancy is the perceived heterogeneity of patients with chronic
non-specific low back pain. It is felt that the effects of treatment may be diluted by the application
of a single intervention to a complex, heterogeneous group with diverse treatment needs. This
argument presupposes that current treatment is effective when applied to the correct patient.
An alternative perspective is that the clinical trials are correct and current treatments have limited
efficacy. Preoccupation with sub-grouping may stifle engagement with this view and it is important
that the sub-grouping paradigm is closely examined. This paper argues that there are numerous
problems with the sub-grouping approach and that it may not be an important reason for the
disappointing results of clinical trials. We propose instead that current treatment may be ineffective
because it has been misdirected. Recent evidence that demonstrates changes within the brain in
chronic low back pain sufferers raises the possibility that persistent back pain may be a problem of
cortical reorganisation and degeneration. This perspective offers interesting insights into the
chronic low back pain experience and suggests alternative models of intervention.
Summary: The disappointing results of clinical research are commonly explained by the failure of
researchers to adequately attend to sub-grouping of the chronic non-specific low back pain
population. Alternatively, current approaches may be ineffective and clinicians and researchers may
need to radically rethink the nature of the problem and how it should best be managed.

Background
Low back pain (LBP) is a substantial health problem. It
affects up to 80% of the adult population [1] and accounts

for considerable healthcare and socioeconomic costs [2].
International guidelines for the management of LBP recommend an initial triage to facilitate effective manage-
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ment of the problem [3]. This classification process
differentiates between specific spinal pathology, nerve
root pain and simple or non-specific low back pain
(NSLBP) [4]. Most authorities suggest further staging the
problem by symptom duration into acute, sub acute or
chronic [5-7]. NSLBP represents about 85% of LBP
patients seen in primary care [8] and the vast majority of
LBP patients seen by physical therapists are classified
under this label.
The prognosis for acute NSLBP (ANSLBP) is relatively
favourable. A significant percentage of sufferers, probably
over 50%, do not consult a health care professional for the
problem [9]. Among those who do seek care, most will
experience rapid improvement in pain and disability
within the first three months [10]. Beyond this time the
majority no longer consult and will continue to experience only low levels of pain and disability, and most have
returned to work and their usual daily activities [10-12].
In a small group of acute patients, the problem fails to
resolve as it should. Perhaps 10% will go on to develop
chronic, disabling LBP [12-14]. It is this group that utilises
the majority of resources allocated [11] and subsequently
there has been a considerable research effort to develop
and evaluate effective treatments for this group.
Recent systematic reviews of the most commonly applied
treatments reach remarkably similar conclusions. Most
treatments provide small, short-term benefits when compared to no treatment or sham treatment, but offer little
benefit when compared to other forms of intervention
[15]. No treatment seems to be superior to any other intervention, including usual GP care [7,15-17]. Furthermore,
none of the cited interventions can be truly said to offer a
solution to the problem of chronic NSLBP (CNSLBP).
Although the magnitude of an individual's problem may
be reduced, the reduction is typically small and the problem still persists [7,17,18].
Recent work evaluating the clinical importance of outcome in CNSLBP reinforces this perspective. Keller et al
[19] calculated the effect sizes for a number of conservative interventions when compared to a no treatment control group. Acupuncture, exercise and psychological
treatment demonstrated moderate effect sizes for shortterm pain relief. Small effect sizes were seen for manual
therapy and electrical stimulation. Effect sizes for shortterm changes in function were small for exercise and psychological treatment. Long-term data were only presented
for exercise, which demonstrated small effect sizes for
both pain and function. They concluded that there is a
dire need to develop more effective interventions for
CNSLBP.
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van Tulder et al. [20] evaluated the effect size of exercise
based treatments for CNSLBP by relating the between
group difference in outcome to the minimal clinically
important difference (MCID) for that outcome. Of 37 trials analysed, only seven showed a clinically important
improvement in outcome. The same group performed a
meta-regression on trials of exercise for CNSLBP in an
attempt to determine the characteristics of exercise that
may optimise outcome from this intervention [21]. A
multivariate model including the most effective intervention characteristics had only a 4% chance of producing
clinically meaningful change in function when compared
to no treatment and a 1% chance of producing meaningful improvement in function when compared to other
conservative treatment. There was a 29% chance that the
expected improvements in pain would be clinically meaningful in comparison to no treatment and a 3% chance
when compared to other active treatment.
The disappointing results from clinical trials may be interpreted in two ways. Firstly, it is possible that the clinical
trials are wrong. That is, for various reasons, the clinical
trial process fails to capture the reality of the clinical setting and underestimates the true effectiveness of current
practice. Alternatively, the clinical trials are right and current approaches to the management of CNSLBP are of
limited value.
The former perspective is one commonly taken by clinicians who feel the results of clinical trials are at odds with
their clinical experience. Numerous explanations have
been proffered, including insufficient treatment dose
[22], inappropriate patient selection [23,24], unsuitable
treatment protocols [25] and outmoded treatment [26].
Probably the most commonly encountered explanation
relates to the perceived heterogeneity of the CNSLBP population and the failure of research to adequately account
for this heterogeneity. Many authors feel that CNSLBP is
made up of several distinct sub-groups, each reflecting different mechanisms of symptom production [27-29]. It is
argued that the effects of treatment are diluted by the
application of a single intervention to a complex, heterogeneous group with diverse treatment needs [28-33]. The
consequence of this assertion is that sub-groups within
the CNSLBP population need to be identified to enable
matching of the intervention with each specific mechanism [28,29,31,32]. This approach has within it the
assumption that current interventions are appropriate and
will ultimately be shown to be successful, if only they can
be applied to the correct patient.
The alternative interpretation, that the clinical trials are
correct and current practice offers little benefit, is often
neglected, and along with it the research agenda that
would have as its priority the development of new and
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novel models of care for CNSLBP. The purpose of this
paper is to encourage clinicians to consider this alternative. Particularly, that for management to move forward
clinicians may need to regard CNSLBP in a very different
way. We will attempt to do this in two ways. Firstly, we
feel that the sub-grouping paradigm potentially stifles
engagement with this view and believe it is important that
clinicians and researchers more closely scrutinise the subgrouping approach. Accordingly, the first section of the
discussion attempts to do this by considering possible
weaknesses in the sub-grouping perspective. Secondly, an
alternative model for understanding CNSLBP will be presented, which offers potential for very different ways of
managing the problem

Discussion
Sub-grouping is only one of a number of possible
explanations for the manifestations of CNSLBP
What clinicians and researchers mean by a sub-group is
not always clear. Sometimes it may refer to clustering of
effect modifiers within a distinct diagnostic group, what
may be referred to as a 'clinical sub-group'. Other times
the term is used to indicate groups with a unique mechanism or cause underlying the disorder, the terms 'aetiological' or 'mechanistic sub-group' probably best capture this
perspective. Both are seen in the LBP literature, for example the three major categories in the McKenzie approach
[34] can be thought of as mechanistic sub-groups,
whereas the sub-classifications of 'derangement' by directional preference and symptom distribution represent
clinical sub-groups under this single mechanistic
umbrella. Likewise, O'Sullivan [35] has proposed three
broad mechanistic sub-groups for CLBP. These have similarly been divided into clinical sub-groups; the broad aims
of treatment are the same for each mechanistic sub-group
though the specifics of intervention vary within the clinical sub-classifications. It is mechanistic sub-grouping that
is under discussion in this paper. Patients' presentations
and responses to treatment will always vary and require
personalisation of care. However, it is important to consider if these variations need be interpreted as indicating
distinctly different mechanisms underlying the disorder.

The statistical problems and pitfalls of sub-grouping have
been reviewed extensively in the literature [36-38]. However, other forms of bias in the construction of mechanistic sub-groups have been less often discussed. In
particular, it is possible that a form of confirmatory bias
pervades aspects of the sub-grouping argument [39]. That
is, explanations for the phenomena of LBP other than
sub-grouping are not considered. There are a number of
characteristics of the LBP experience that have prompted
the proposition of a sub-grouping approach, and while
sub-grouping is consistent with these, it is worthwhile to
consider other potential explanations.
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There is no doubt that CNSLBP represents a complex,
multi-dimensional problem. The chronic LBP experience
is characterised by a vast array of physical [40-42] and psychosocial [43,44] features. It is this complexity that is
cited as a compelling argument for the existence of distinct mechanistic sub-groups within the CNSLBP population [31,45]. Complexity in presentation does not have to
be interpreted as evidence of distinct mechanisms. The literature is replete with descriptions of the same degree of
physical and psychological intricacy within discrete diseases [46-52]. In these examples, the presence of a single
disease gives rise to a host of physical and psychological
characteristics. As with LBP, these characteristics contribute to the consequences of the problem to that individual.
The understanding of this complexity is vital in helping
personalise treatment and determining best how treatment goals may be obtained for each patient. However,
there is a distinction between varying and personalising
individual care within a single framework and seeking distinctly different modes of care.
The multi-dimensional nature of CNSLBP may also be
interpreted in this way. While complexity in behaviour
can be explained by distinct mechanistic sub-groups, it
can equally be interpreted as the individualisation of
response to a single underlying problem, and while the
complexity of the presentation requires that intervention
be broad and personalised it may still have as its basis a
single idea.
Not only is CNSLBP complex, it is also possible to observe
clustering of various characteristics in this population
[31,33,53,54]. Historically, diagnosis has been driven by
labelling clusters of signs and symptoms [55] and in
CNSLBP it may be that these clusters represent different
mechanisms requiring different interventions [28]. However, it is again worth considering other explanations.
Researchers have repeatedly demonstrated grouping of
characteristics in patients with specific disease processes.
For example, patients with Parkinson's disease may be
stratified by rate of clinical progression [56] and individuals with sickle cell disease can be grouped by level of fear
avoidance [57]. Clustering of signs and symptoms will
almost always be possible within single disease entities.
One reason for this is variability in the severity of the condition. It is a reasonable prediction that those patients
whose condition is less severe will exhibit different signs,
symptoms and behaviours to those whose condition is
moderate or those whose condition is severe. Clustering
in presentation does not necessarily represent evidence of
separate mechanisms. Different mechanisms may explain
clustering, but equally it is possible to see and explain this
phenomenon in problems with a single aetiology.
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Another consideration is the variability seen in clinical trials of treatment for CNSLBP. Most commonly applied
interventions have been subject to numerous studies, and
for any given intervention it is possible to identify some
studies in which there is a demonstrated effect and others
in which there is no effect. Failure to account for subgroups within the LBP population has again been cited as
a potential explanation for these findings [38,32].
There are several alternative explanations that are worthwhile contemplating. Firstly, statistical power may underpin some of the variability seen. The inconsistency does
not necessarily reflect variability in treatment efficacy, just
variation in the statistical efficiency of studies to detect
treatment effects. Secondly, there is likely to be some random error associated with a large number of studies. One
would expect to see most studies yield results representative of the average effect of that intervention. Likewise,
there would be some variability in the response, with a
few studies showing effects greater than the average and a
few studies showing effects lower than the average. The
variation may simply be noise, rather than variability
induced by "innovative trial design" [32]. Finally there is
some suggestion that authorship may influence the interpretation of results. Variability in the outcome of clinical
trials may simply reflect different interpretations of effect
sizes by authors [58,59], rather than evidence of bias in
trial design or greater attention to sub-grouping.
A further commonly applied argument for the pursuit of
mechanistic sub-groups is that NSLBP is too broad a category. Researchers suggest that since the majority of low
back pain patients fall into this category, it's value in characterising a patient's presentation is only marginally more
helpful than simply stating that they have pain in the back
[31,40]. NSLBP is indeed a broad category, representing
the vast majority of those who develop a complaint of
back pain. However, CNSLBP represents only a small percentage of this population, probably less than 10% [1214]. It is a highly stratified group, representing that collection of patients whose symptoms were severe enough to
warrant consultation, who had neither specific spinal
pathology nor nerve root pain and whose symptoms
failed to settle in the usual time frame.
This section concludes that a number of the features of
CNSLBP can be explained by mechanisms other than the
inculcation of mechanistic sub-groups. This does not
invalidate sub-grouping, it merely recognises that it is one
of several alternatives. A more robust critique of the subgrouping perspective requires consideration of the predictions that a sub-grouping model makes, and investigation
of data related to these predictions. This is the aim of the
next section.
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Clinical studies on CNSLBP do not strongly support the
presence of mechanistic sub-groups
Supporters of the sub-grouping model contend that the
small effect sizes seen in clinical trials result from the large
positive effects seen in some patients being 'washed out'
by the smaller or negative effects seen in others [32]. The
solution offered for this problem is the matching of a
diagnostic profile with the type of intervention best suited
to that profile [32]. If this is the case there are a number of
reasonable predictions that can be made from the clinical
literature. Firstly, it would be expected that a treatment
process that is derived from a patient examination and tailored to the individual's presentation would be superior
to a treatment process that is not. Secondly, multimodal
care is likely to be superior to unimodal care as there is
less chance of 'washout' of treatment effect. Thirdly it
should be possible to identify groups of patients who
respond favourably to one form of treatment and less
favourably to alternative treatments.
Specific versus non-specific treatments
Several different protocols have been used that compare
tailored to non-tailored treatment programmes, and all
reach similar conclusions. Comparisons between treatment programmes based on individual patient assessment and more general and generic treatment
programmes demonstrate equivalence in outcome [6068]. Providing therapists with the opportunity to assess
patients and provide them with the care they consider best
addresses the mechanism underpinning their disorder
does not seem to be better than treatment that is generically applied. Patients participating in general physical
activity appear to do better than those engaged in specific
back exercises [69] and level of training and experience of
the therapist, presumably allowing more appropriate
matching of treatment with the patients' profile, seems
not to impact on outcome [70]. Overall, there seems to be
little support for the view that specific, individualised
treatment produces better outcome.

Kent and colleagues [71] systematically evaluated this perspective for manual therapy using meta-analysis. Their
review compared the effects of manual therapy when therapists were free to select the intervention used, to studies
in which the manual therapy treatment was prescribed.
They were unable to detect any difference in outcome
between these two conditions. Using a robust methodology, this group found no support for the perspective that
individualised and clinically reasoned interventions are
superior to generically applied interventions.
Hayden et al [21] compared outcome from individually
tailored exercise programmes, which presumably sought
to address the mechanisms underlying a patient's disorder, to standardised programmes. Individually designed
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programmes had no effect on function in comparison to
general programmes and only a small and clinically
unimportant influence on pain.
Unimodal versus multimodal care
If the CNSLBP population contains distinct mechanistic
sub-groups requiring different intervention strategies,
then a reasonable prediction would be that multimodal
interventions demonstrate superior outcomes to unimodal care, particularly when the unimodal components
have been shown to impart some benefit to patients. The
sub-grouping model would predict that subjects in multimodal care have a greater likelihood of receiving their
appropriate intervention, thus decreasing the chance of
'washout'. While there is a possibility that treatments may
interact negatively, or in other complex ways, we consider
this a reasonable prediction. While some papers show
small differences with the addition of treatments [72-74],
the majority of studies report no difference when unimodal and multimodal approaches are compared [68,7584]. Increasing the likelihood that patients are exposed to
the 'correct' treatment does not seem to enhance outcome.

Hayden et al [21] again provide systematic and methodologically rigorous information on this perspective. They
compared exercise only groups with groups that received
exercise and additional therapy. The addition of other
conservative care to exercise therapy for CLBP patients
produced only small and clinically insignificant changes
in pain and function.
Sub-group response to treatment
One approach to investigating sub-grouping in LBP is to
consider which cluster of patient factors identify those
most likely to benefit from a particular treatment.
Research on ALBP, for example, has identified distinct and
theoretically plausible clinical profiles that predict success
from manipulation [85] and stability training [86] and
preliminary evidence suggests that grouping patients this
way makes a significant difference to outcome [87,88].

If CNSLBP is similarly made up of different mechanistic
subgroups, and a particular intervention is applied to the
whole group, those patients that are matched to that treatment should obtain benefit and their clinical profile
ought to emerge from analyses of treatment moderators.
There have been many attempts to elucidate the features
that influence outcome in CNSLBP patients receiving care.
These data are difficult to interpret. The results are influenced by the type of outcome investigated and the followup interval [89]. In addition, there is great variability in
the potential predictors that have been investigated, making comparison and synthesis difficult [90] and interpretation is often confounded by lack of a comparison group
[91].
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While acknowledging these problems, there is little evidence from clinical studies of a patient profile that
responds uniquely to a given intervention. Pain intensity,
duration of the problem and distress appear repeatedly as
important predictors of outcome regardless of the type of
treatment [30,90,92-96]. There is a sense that the characteristics of patients who do poorly or well with treatment
are the same regardless of the intervention [92,93] and
may simply be a reflection of severity. Unlike the situation
in ALBP [85,86,97] it has not yet been demonstrated that
the chronic population contains unique groups that
respond differently to different interventions.
What else may explain the disappointing treatment
results?
In the previous sections we saw that the features of
CNSLBP that have prompted clinicians and researchers to
consider sub-grouping may have alternate explanations
and that clinical data on CNSLBP does not strongly support the presence of sub-groups. Despite its popularity,
sub-grouping may not be an important explanation for
the disappointing results seen in clinical trials. An alternative perspective is that treatment has been ineffective
because it has been misdirected. One possible scenario is
that the problem of CNSLBP does not lie within the back,
but within the brain. Thinking of CNSLBP as a problem of
cortical reorganisation and degeneration may increase our
understanding of the problem and more appropriately
direct intervention.

There is growing evidence that the brains of patients with
CNSLBP are different to those of normal subjects [98-102]
and there are corresponding alterations in brain function
[99,103,104]. Herta Flor's group [99] provided the initial
data in this area. They recorded evoked magnetic fields in
the brain in response to electrical stimulation of the back.
They demonstrated greater reactivity in the primary somatosensory cortex (S1) and an expansion of the S1 representation of the back in CLBP patients. Altered S1
representation is also a feature of other complex pain
problems [105,106].
Recently investigators have looked more widely at brain
structure and function, and a consistent pattern of brain
changes has begun to emerge. Siddall et al. [101] used
magnetic resonance spectroscopy (MRS) to monitor biochemical changes in the anterior cingulate cortex, prefrontal cortex and thalamus of 32 CLBP patients. This method
was highly accurate in distinguishing CLBP patients from
normal volunteers. Grachev et al. [100] also studied the
biochemical profile of these three brain regions. They
looked at the concentrations of nine different metabolites
using proton MRS. Again there was strong evidence for
alterations in the biochemical profile of CLBP patients,
most notable was evidence of neurodegeneration within
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the dorsolateral prefrontal cortex (DLPFC), a result replicated more recently in a group of depressed CLBP patients
[107].
Brain morphometry has been used to investigate both
general and regional gray matter density changes in CLBP
patients. Apkarian et al. [98] reported a greatly decreased
neocortical gray matter volume in patients compared to
matched controls. Regional analysis supported the biochemical data, with the DLPFC showing the greatest
extent of loss. Less extensive gray matter loss was also
noted in the thalamus. Schmidt-Wilke et al. [102] also
found gray matter loss in the DLPFC of CLBP patients as
well as decreased volumes in S1 and the brainstem. This
group also reported small increases in density in the thalamus and basal ganglia. Finally Honda et al. [108]
looked at cerebral blood flow in CLBP patients as part of
a larger study on diverse chronic pain states. Again the
DLPFC featured, demonstrating decreased blood flow at
rest. Decreased blood flow was also observed in the orbitofrontal cortex and anterior cingulate cortex.
Alteration in brain function may be the mechanism that
underpins the problem of CNSLBP. The patterns of central
changes are consistent across a number of studies and
methodologies and the extent of the central nervous systems changes are proportional to the duration and severity of the condition [98,99,102]. Indeed, Baliki et al. [109]
suggest that brain changes account for over 70–80% of the
variance for intensity and duration of CLBP. Cross-sectional studies always raise the problem of causality, and
while there is no equivalent information on CNSLBP,
some small longitudinal studies on other pain problems
characterised by altered cortical function suggest that
interventions directed at cortical processing may be effective [110-113], in two studies more effective than conventional care [111,113]. Furthermore, good outcome is
strongly related to normalisation of cortical function
[114,115].
A cortical model of CNSLBP must be able to explain the
complex clinical presentation of the problem. Critical
challenges include accounting for the innumerable physical and psychological manifestations of CNSLBP and
offering an explanation for the equivalence in outcome of
very disparate treatments. Though speculative, alteration
in brain function may offer some interesting perspectives
and insights into these issues.
Pain in the absence of meaningful spinal pathology
There is now strong evidence that structural changes
within the spine have little meaning in the context of
CNSLBP [18,116,117]. Recent evidence suggests that
structural abnormalities have little impact on the outcome of conservative treatment [118] and invasive inter-
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ventions, specifically designed to address putative
peripheral pathology, appear to offer little benefit to
patients [16,116,119]. Pain beyond the normal healing
time or in the absence of any meaningful peripheral
pathology has long been a challenge in the understanding
of CNSLBP.
Sensitization of the nociceptive system is one suggested
explanation for this problem. Enhanced synaptic efficiency of nociceptive networks may facilitate the perception of pain with little or no peripheral nociceptive input.
Evidence indicates that there is some degree of sensitisation in CNSLBP patients [99,120,121]. Theoretically, this
may be the result of changes in the periphery, the spinal
cord [122,123], the brain [124] or in a combination of
these areas.
Studies of inflammatory and neuropathic pain models in
animals demonstrate extensive structural and functional
alterations in the dorsal horn of the spinal cord that represent a relatively specific degeneration of the inhibitory
interneurone system, leading to central sensitization and
increases in pain-related behaviours (for review see
[122]). Similar changes in the dorsal horn have been demonstrated post-mortem in human subjects who had suffered from post-herpetic neuralgia [125]. While it must be
considered that CNSLBP develops in the absence of
demonstrable peripheral nerve injury it is possible that
the initial afferent nociceptive barrage that follows acute
spinal injury may induce lasting alterations in dorsal horn
function that lead to the maintenance of pain after tissue
healing has occurred.
Methodological barriers to studying cord structure and
function in humans make it difficult to ascertain the contribution of such changes to CNSLBP. Furthermore, in
rodents, the spinal cord represents a far greater proportion
of the CNS than in humans, and animal models demonstrate that while cord changes are prevalent in younger
animals, brain changes dominate in older animals [126].
Nevertheless, the animal data is important as it suggests a
common aetiology of neurodegeneration. While there is
currently no evidence of spinal cord changes in CNSLBP
patients, there is significant data on altered brain function
[99,103,121,124,127]. It could be argued that supraspinal
changes may be more likely to drive the sensitised state
seen in human subjects with CNSLBP.
The work on brain changes in CLBP patients provides
speculative support for this view. Schmidt-Wilke et al.
[102] demonstrated gray matter degeneration of the
brainstem, an area highly associated with inhibitory pain
control, potentially leading to a loss of anti-nociception
and the promotion of a sensitised state. There is also
strong evidence for the role of the DLPFC in pain modu-
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lation and inhibition. Activity in the DLPFC has been
shown to be negatively correlated with pain intensity and
unpleasantness [128]. This area appears to have a role in
affective disengagement from pain [129] and activity in
this region is negatively correlated with the degree of pain
related catastrophising [130]. These functions are likely to
be affected by the extensive DLPFC degeneration seen in
CLBP. In support of this idea, Baliki et al. [109] have
shown that the sustained spontaneous pain of CLBP is
strongly associated with increased activity of the medial
pre-frontal cortex (mPFC) and suggest that this is the
result of a loss of inhibitory control of the mPFC from the
DLPFC.
A second proposition for the perception of pain in the
absence of spinal pathology is the presence of central pain
memories. Flor [131] has suggested that the alterations in
sensory cortical representation found in chronic pain represent the neuronal substrate of implicit pain memories
that serve to maintain and enhance pain perceived in the
affected body region. As well as providing a mechanism
for the maintenance of ongoing back pain, this may help
to explain how previous episodes of low back pain lead to
the development of chronicity, by contributing to and
reinforcing these pain memories.
An alternative mechanism has been proposed by which
cortical reorganisation may lead to the generation of
ongoing, movement related pain from within the brain.
Harris [132] suggests that altered cortical representation
of somatic input may falsely signal incongruence between
motor intention and movement. The generation of motor
activity within the central nervous system is closely coupled to sensory feedback systems, which are monitored to
detect any deviation from the predicted response [133]. If
there is conflict between motor output and sensory feedback, it is hypothesised that pain is produced as a warning
signal to alert the individual to abnormalities within
information processing [133]. Alteration of the lumbar
spine's representation in S1 [99] may be the substrate of
abnormal proprioceptive representation of the back and
therefore a possible source of sensory-motor incongruence.
McCabe et al. [133] provided some experimental support
for this hypothesis by inducing pain in healthy volunteers
moving in an environment that created a degree of sensory-motor conflict. These results have attracted some criticism [134] and research using an alternative
methodology to disrupt cortical proprioceptive representation was unable to evoke pain [135]. It is worth considering that CNSLBP develops following an initial painful
event and it is arguable that sensory-motor conflict may
have more potential for generating pain when the pain
'matrix' is in a sensitised state.
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Lack of visual input of the moving part is a critical component of the incongruence hypothesis [132]. Vision has a
dominant role over other senses in self-recognition, and
many studies demonstrate that body position sense is recalibrated to conform to visual information (for review
see Jeannerod [136]). Thus the lumbar spine, which is not
directly visualised during task performance, may be more
susceptible to this problem as abnormal cortical proprioceptive representation cannot be 'corrected' by visual feedback.
Interestingly, conditions that generate sensory-motor conflict are associated with increased activation in the right
dorsolateral prefrontal cortex (DLPFC) [137]. As mentioned above structural neurodegeneration and altered
activity of the DLPFC is a consistent finding in patients
with CNSLBP [98,102,107], additionally a number of
studies have shown these changes are localised to the right
hemisphere [102,107]. Apkarian et al. [98] suggest excitotoxicity secondary to long-term potentiation as a possible
cause of this degeneration. One possible candidate for
inducing these changes is over-activation secondary to
sensory-motor incongruence.
In summary, there are numerous ways whereby reorganisation within the brain may generate persistent pain in the
absence of ongoing peripheral pathology. These include,
reduced cortico-cortical and descending inhibition producing an abnormally sensitised state, the reactivation of
implicit pain memories, and centrally generated pain in
response to sensori-motor incongruence when the patient
moves the back. It is plausible that these mechanisms
coexist. It is currently unknown to what extent that these
brain changes are reversible. Similar but distinct brain
changes are noted in phantom limb pain and CRPS I, and
both these conditions appear amenable to treatment
directed towards the brain [110-114]. If some of the
changes noted are not reversible it might still be possible
to alter pain by affecting processing within this altered system.
Biomechanical manifestations of CNSLBP
The biomechanical aspects of LBP have been widely investigated [138], and the range of mechanical manifestations
seen in CNSLBP patients is vast. The back is moved less
during functional tasks [139-143] and there is greater
asymmetry and variability in performance [140,144,145].
There is a consistent decrease in the velocity of movement
[146-148]. Muscles are activated in a dys-coordinated
manner in static and dynamic situations [149,150]. When
lifting, the back muscles are recruited earlier and stay on
for longer and there is a greater amount of co-contraction
[151-153]. There are altered patterns of muscle recruitment with limb movements [154], with sudden loading
and unloading [155-158], and balance is impaired
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[157,159-162]. There is some suggestion of poorer proprioception [163-165] and there are delays in reaction
times to a variety of tasks [166-168].
The congruence seen within these data is surprising. The
overwhelming sense is a loss of confidence, control and
coordination within the back. While Moseley and Hodges
[169] contend that it is unclear if these abnormalities are
compensatory, causative, neither or both, a common
approach is to interpret these findings as causative. Poor
stability and control is thought to influence loading of the
lumbar spine and sustain the production of peripheral
nociceptive input [35,154,170,171]. Within this framework treatment is directed towards normalising motor
performance based on a peripheral biomechanical model.
However, it may be that these physical abnormalities are
not causative but result from altered higher centre representation and the individual's attempts to maintain function with an altered body schema. It is conceivable that
these features are epiphenomena of cortical dysfunction
rather than the underlying mechanism of CNSLBP. If this
is the case treatment guided by a biomechanical explanatory model might be misdirected.
Support for this view can be seen in a number of areas.
There appears to be little association between changes in
patient centred outcome and changes in any aspect of low
back related physical performance [117]. Lumbar stabilisation training programmes, which interpret these problems as causative and specifically address them from a
biomechanical perspective [172] and other active [173]
and passive [174] interventions aimed at changing the
mechanical behaviour of the lower back demonstrate limited clinical effectiveness.
Psychological manifestations of CNSLBP
Psychological factors are an important part of the chronic
LBP experience. They contribute to the progression to
chronicity, explain a significant amount of the variance
among CLBP patients and have been identified as important barriers to resolution [44,175,176]. Alterations in
brain function offer some additional insight into the role
psychological features play in the development of
CNSLBP and the maintenance of the problem once it is
established.

Pincus et al. [175,176] cite distress/depressive mood as
integral psychological factors in the transition from acute
to chronic LBP and several psychosocial models have
been postulated for the role of distress/depression in this
transition [176,177]. Although speculative, brain reorganisation may also be significant. It appears that there is considerable overlap in the neural circuitries of the brain in
both depression and CLBP [107]. It is of particular interest
that alteration of DLPFC function has been strongly
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implicated in depressive disorders [178,179]. Although its
precise role is currently not clearly defined [180,181], evidence points to primary abnormal activity within the
DLPFC [107]. Depressed CNSLBP patients have been
shown to have evidence of DLPFC degeneration and the
level of degeneration was highly correlated with the level
of depression [107]. One mechanism by which depressed
mood influences chronicity may be via contributing to
DLPFC degeneration.
Psychological variables also account for a significant
amount of the variance in the CNSLBP condition [44].
Despite their explanatory value, the evidence for the efficacy of psychologically based treatments is not strong.
Psychologically focused treatment only delivers small
effects on pain and function when compared to no treatment [7]. They seem to be no more effective than other
active interventions [7,117,182] and provide little additional benefit when added to other conservative treatment
approaches [84,117,183]. The brain changes seen in
CNSLBP may help explain this situation.
The fear-avoidance model is seen as a central psychological mechanism in the maintenance of CNSLBP [184,185].
Fundamental to this model are the opposing behavioural
responses of confrontation and avoidance. Confrontation
is seen as adaptive and likely to lead to resolution. Alternatively, avoidance is thought to be maladaptive and contribute powerfully to the development of chronicity and
numerous associated biological and psychological sequelae [186]. Catastrophic beliefs and pain related fear are
primarily what drives avoidance [184], and are consequently seen as the primary targets for intervention. The
origins of these beliefs are viewed as a major challenge in
developing the fear-avoidance model [186,187] and
numerous possibilities have been suggested [184-187].
One possible candidate for the genesis of these beliefs is
alteration in cortical representation of the back and resultant distorted body schema. Keefe et al [187] state that fear
may be fuelled by unexpected and novel bodily sensations. Both McCabe et al. [133] and Moseley et al. [135]
demonstrated that strangeness, foreignness and peculiarity are features of moving when there is sensory-motor
incongruence. As with the biomechanical features of
CNSLBP, fear and catastrophising may also be viewed as
responses to an altered body schema. These beliefs would
be a reasonable response to an individual with an altered
cortical representation of their back who experiences
unexplained pain and unexpected and novel sensations
when moving. Treatments that seek to address these problems from a cognitive perspective may be less than ideal,
as the fundamental substrate for the genesis of fear and
catastrophisation would still be present.
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It is also possible that degeneration within the DLPFC
may contribute directly to greater catastrophic interpretation of pain. The DLPFC seems to be important in emotional disengagement from pain [128,129] and it has
been proposed that degeneration of the DLPFC may contribute to the production of spontaneous pain [109],
which may fuel catastrophic thoughts, and, as discussed
above, there is evidence that DLPFC activity is negatively
correlated with catastrophic thinking about pain [130].
Individuals' coping strategies are also considered to be
important contributors to the disability associated with
CNSLBP. Active coping strategies, characterised by efforts
to function in spite of pain or to distract oneself from pain
are thought to be important in adaptive functioning
[188]. Psychological management of CNSLBP seeks to use
distraction and encourages engagement in activity despite
pain, as part of the treatment process [189]. This requires
that the individual is able to let task relevant stimuli to
dominate over pain [128], which can be particularly difficult given the high attentional demands of pain [190].
One suggested role of the DLPFC is in governing efficient
performance in the presence of interfering stimuli [128].
Degeneration of the DLPFC will obviously interfere with
this ability. Patients may not respond to this component
of treatment as the neural substrate for engagement in this
process is not available to them. These views do not challenge the biopsychosocial approach to the management

of CNSLBP. It is abundantly clear that the thoughts, feelings and beliefs of an individual impact significantly on
the problem [4,44,191]. What may require reconsideration is the origins of some maladaptive thoughts and
beliefs and how these may be best modified.
Figure 1. presents a speculative model for the development and maintenance of NSCLBP with altered cortical
function at its core. In the model, current and previous
episodes of back pain contribute to an altered cortical representation of the back. Conceivably, previous episodes of
LBP may also increase distress about the problem. Alterations in proprioceptive representation, subsequent sensory-motor incongruence and pre-existing depressive
mood lead to over-activation and subsequent neurodegenerative change in the DLPFC. Sensory-motor incongruence may also directly produce pain, sustain altered motor
control strategies and contribute to fear and catastrophic
thoughts. The resulting DLPFC dysfunction contributes to
central sensitization and subsequent ongoing and exaggerated pain, and also decreases the patient's ability to disengage from the pain, thus feeding back into the negative
psychological influences. The mechanisms presented in
the model should be acknowledged as speculative but represent an attempt to interpret the alterations in brain function that have been demonstrated in CNSLBP in light of
the clinical manifestations of the condition.

Central
sensitisation

Previous LBP
‘cortical’ or
pathological
pain

Intra-/sub-cortical
Facilitation / decreased
inhibition

Cortical
reorganisation
New episode
of low back
pain:
Peripheral
nociceptive
input

Distress
Somatisation
and
hypervigilance

Activation of
the central
pain
neuromatrix

Depression

Change in cortical
representation of
somatosensory
input
Implicit pain
memory formation

Change in
internal body
schema
Proprioceptive
deficiency
(Inability of
vision to
compensate)

Sensory-motor
incongruence with
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Motor control
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and co contraction
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Feelings of
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Figure
A
Cortical
1 Dysfunction Model of Chronic Non Specific Low Back Pain
A Cortical Dysfunction Model of Chronic Non Specific Low Back Pain. Abbreviations: LTP = Long Term Potentiation, DLPFC
= Dorsolateral Prefrontal Cortex, mPFC = medial Prefrontal Cortex.
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In summary, CNSLBP patients have back pain yet no conservative or surgical pain relieving measures directed at
the back appear effective. They display a number of biomechanical abnormalities, however treatment directed at
normalising lumbar biomechanics has little effect and
there is no relationship between changes in outcome and
changes in spinal mechanics. Finally, these patients demonstrate some psychological problems but psychologically based treatments offer only partial solution to the
problem. A possible explanation for these findings is that
they are epiphenomena, features that are incidental to a
problem of neurological reorganisation and degeneration.
Equivalence of treatment effects
As discussed, the response of CNSLBP patients is very similar across a broad range of treatment options. A simple
explanation would be to conclude that current interventions are ineffective or demonstrate only non-specific or
placebo effects. However, the evidence does not support
either of these perspectives. Most commonly applied conservative treatments demonstrate some level of effectiveness, albeit small, and this seems to be above what is
produced by sham treatment [15]. Alternatively, disparate
treatments may demonstrate equivalence in outcome
because they all work through the same mechanism. Massage, manipulation, exercise, acupuncture, education and
other interventions may work by influencing cortical
function. The effectiveness is comparable across treatments because the pathway by which they act may be the
same.

This perspective may also explain the disappointing effect
sizes seen with conservative care. A possible reason for the
small effects seen is that none of these interventions are
currently delivered in a way that focuses on central
processing. Mobilisation of the lumbar spine might be
made more cortically directed by having the patient
respond verbally to the stimulus, trying to localise the
level or determine direction of pressure, akin to the sensory discrimination task employed by Flor et al. [114] in
managing phantom limb pain or by Moseley et al. [192]
in CRPS. Exercises aimed at improving trunk muscle
recruitment seem an ideal way to normalise cortical representation, but rather than emphasis being placed on performing a particular type of muscle recruitment pattern
based on a peripheral biomechanical model
[154,170,171] participation in a variety of challenging
exercises may be more useful. Simply mastering any skill
that the patient finds difficult may be all that is required.
Similar thinking can be applied to most commonly
applied conservative interventions, and whilst changing
the emphasis of existing treatments may be a viable
option for enhancing clinical efficacy, it may also be use-
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ful to consider other possibilities. There is mounting evidence for the effectiveness of alternative and innovative
strategies for "re-training" cortical function in other complex, long standing, pain problems [110-114,193] as well
as recent data that training of brain activation with functional MRI can favourably influence chronic pain [194].
Advances in non-invasive brain stimulation techniques
such as repetitive transcranial magnetic stimulation and
transcranial direct current stimulation also offer
approaches for altering cortical function to achieve pain
relief [195,196] and to enhance cognitive function [197199]. The challenge presented by this model for researchers and clinicians is to determine how therapy might be
designed to address cortical function.
In conclusion there is little evidence to endorse current
treatment for CNSLBP. Most treatments provide only
small short-term changes and there is currently scant evidence that one form of treatment is superior to another.
Sub-grouping of CNSLBP is a common response to these
disappointing results. The sub-grouping perspective is not
consistently supported by the available data and it is
important that other research agendas are entertained. An
alternative perspective is that treatment has been ineffective because it has been misdirected. CNSLBP may be a
problem of abnormal cortical function. There is growing
evidence of supraspinal abnormalities in CNSLBP, these
mechanisms can potentially explain the complexity of the
LBP experience and the outcomes of clinical trials on
CNSLBP. Various research groups have demonstrated the
potential value of 'training the brain' in other conditions
characterised by abnormal cortical processing. Given the
growing body of evidence indicating similar neural mechanisms in CNSLBP, the development of clinical strategies
targeted at normalising neurological processing represents
a challenging new direction for musculoskeletal clinicians
and researchers involved in the management of CNSLBP.

Summary
• Clinical trials offer little support for current management of chronic non specific low back pain
• Sub-grouping has been commonly offered as an explanation for the disappointing results of clinical trials
• Much of the literature on CNSLBP do not strongly support a sub-grouping model
• Evidence is emerging of significant cortical alterations in
CNSLBP patients
These changes may offer an explanation for the complex
problem of CLBP and a potential focus for effective treatment.
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